Advertisement
The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug

FDA Approves Inflectra as ‘Biosimilar’ to Remicade

0
For adults with Crohn's, rheumatoid arthritis, or psoriasis
Emotional distress is common in children during and after therapy for childhood acute lymphoblastic leukemia

Distress Still High After Chemo Completion in Childhood ALL

0
Need for targeted early screening, psychosocial interventions to help patients, families at this time
For patients with worsening heart failure

Diuretic Dose Not Linked to Outcome in Heart Failure

0
In multivariate analysis, no correlation seen for patients with worsening heart failure
Expert consensus guidance has been issued regarding the use of non-statin therapies to lower cholesterol in high-risk patients. The consensus document was published online April 1 in the Journal of the American College of Cardiology to coincide with presentation at the annual meeting of the American College of Cardiology

ACC: Expert Guidance Issued for Use of Non-Statin Therapies

0
Authors recommend addition of ezetimibe at 10 mg/day for higher-risk patients
The price of insulin has tripled in only 10 years

Cost of Insulin Found to Have Tripled Over Past Decade

0
Since 2010, per-person costs topped spending on all other diabetes drugs combined
New research adds to growing evidence that bariatric surgery helps patients with type 2 diabetes lower their blood glucose levels for at least five years. The findings were presented at the annual meeting of the American College of Cardiology

ACC: More Evidence of Long-Term Benefits of Bariatric Surgery

0
After five years, more patients in surgery group had lower blood glucose than in medication-only group
Consumption of processed carbohydrates and sugary drinks may affect risks of breast and prostate cancers

Glycemic Load Tied to Breast, Prostate Cancers

0
Preliminary study finds more reasons to improve diet
Diabetes medications containing saxagliptin and alogliptin may raise the risk of heart failure

FDA Issues New Warning for Two Diabetes Medications

0
Drugs containing saxagliptin or alogliptin may be linked to heart failure risk
Hispanics/Latinos frequently have cardiac dysfunction

Subclinical Cardiac Dysfunction Frequent in Hispanics/Latinos

0
High rate of left ventricular diastolic dysfunction; most cardiac dysfunction is subclinical, unrecognized
The number of adults worldwide with diabetes has quadrupled in the past 35 years

Since 1980, Diabetes Cases Have Quadrupled Globally

0
Major increases seen in low- and middle-income countries such as China and India